GenEng News  Jul 10  Comment 
Convinced that their third Phase III trial assessing Fovista ® (pegpleranib) in wet age-related macular degeneration (AMD) may be as unsuccessful as two earlier pivotal studies of the candidate, Ophthotech disclosed today that it has joined...
FierceBiotech  Jul 10  Comment 
Ahead of the first-ever FDA AdComm for a CAR-T medication, the agency says experts should focus on the safety side of the new med, more than efficacy.
FiercePharma  Jul 10  Comment 
Here comes the second challenger to Pfizer’s fast-growing breast cancer medication Ibrance. On Monday, the FDA put Eli Lilly’s abemaciclib on a quicker path to approval, and if it can get there, it will be the third entrant in the CDK 4/6...
The Economic Times  Jul 6  Comment 
Novartis said that the Committee for Medicinal Products for Human Use has approved a label update for Cosentyx, the first interleukin-17A approved to treat psoriasis.


Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki